Found: 6
Select item for more details and to access through your institution.
Novel Combination Treatments Targeting Chronic Myeloid Leukemia Stem Cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 2, p. 94, doi. 10.1016/j.clml.2011.10.003
- By:
- Publication type:
- Article
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 187, doi. 10.1016/j.cllc.2021.01.001
- By:
- Publication type:
- Article
Erlotinib and Bevacizumab in Newly Diagnosed Performance Status 2 or Elderly Patients With Nonsquamous Non-Small-Cell Lung Cancer, a Phase II Study of the Hoosier Oncology Group: LUN04-77.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Erlotinib and Bevacizumab in Newly Diagnosed Performance Status 2 or Elderly Patients With Nonsquamous Non-Small-Cell Lung Cancer, a Phase II Study of the Hoosier Oncology Group: LUN04-77.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 3, p. 224, doi. 10.1016/j.cllc.2012.09.004
- By:
- Publication type:
- Article
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 733, doi. 10.1007/s11523-020-00753-7
- By:
- Publication type:
- Article
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 743, doi. 10.1007/s11523-020-00752-8
- By:
- Publication type:
- Article